Systemic inflammatory response syndrome in patients with acute obstructive upper tract urinary stone: a risk factor for urgent renal drainage and revisit to the emergency department.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
29 Jun 2020
Historique:
received: 11 09 2019
accepted: 18 06 2020
entrez: 1 7 2020
pubmed: 1 7 2020
medline: 19 3 2021
Statut: epublish

Résumé

In patients seen in the emergency department (ED) with acute stone obstruction many risk factors that indicate need for urgent renal drainage are known. However, in patients discharged from ED without renal drainage factors that can minimize revisit to the emergency department are not fully identified. We evaluated SIRS (systemic inflammatory response syndrome) as a risk factor for urgent renal drainage and revisit to the ED in patients with acute stone colic during their ED visit. Retrospective review was performed of patients presenting to a tertiary academic emergency department (ED) from an obstructing ureteral or UPJ stone with hydronephrosis confirmed on an abdominal and pelvic CT scan. Data evaluated over a 3-year period included stone size, presence of UTI, presence or absence of SIRS and other clinical variables as risk factors for urgent renal drainage and ED revisits. 1983 patients with urolithiasis were seen at the ED and 649 patients had obstructive urolithiasis on CT scan. SIRS was diagnosed in 15% (99/649) patients. 54/99 (55%) patients with SIRS underwent urgent renal drainage compared to 99/550 (17%) in non-SIRS patients. In a multivariate analysis SIRS was a predictor of urgent intervention compared to non-SIRS patients (odds ratio 4.6, p < 0.05). SIRS was also associated with increased risk for revisits to the ED (6.9% with SIRS vs. 2.4% with no SIRS, odds ratio 2.9, p = 0.05). Presence of SIRS in obstructive urolithiasis patients was an independent risk factor of acute urologic intervention and revisits to the ED. A timely consultation with a urologist following discharge from ED for obstructive stone patients with SIRS who had no acute renal drainage may prevent revisit to the ED. Evaluation for SIRS in addition to other clinical risk factors should be considered while making management decision in patients with acute stone obstruction.

Sections du résumé

BACKGROUND BACKGROUND
In patients seen in the emergency department (ED) with acute stone obstruction many risk factors that indicate need for urgent renal drainage are known. However, in patients discharged from ED without renal drainage factors that can minimize revisit to the emergency department are not fully identified. We evaluated SIRS (systemic inflammatory response syndrome) as a risk factor for urgent renal drainage and revisit to the ED in patients with acute stone colic during their ED visit.
METHODS METHODS
Retrospective review was performed of patients presenting to a tertiary academic emergency department (ED) from an obstructing ureteral or UPJ stone with hydronephrosis confirmed on an abdominal and pelvic CT scan. Data evaluated over a 3-year period included stone size, presence of UTI, presence or absence of SIRS and other clinical variables as risk factors for urgent renal drainage and ED revisits.
RESULTS RESULTS
1983 patients with urolithiasis were seen at the ED and 649 patients had obstructive urolithiasis on CT scan. SIRS was diagnosed in 15% (99/649) patients. 54/99 (55%) patients with SIRS underwent urgent renal drainage compared to 99/550 (17%) in non-SIRS patients. In a multivariate analysis SIRS was a predictor of urgent intervention compared to non-SIRS patients (odds ratio 4.6, p < 0.05). SIRS was also associated with increased risk for revisits to the ED (6.9% with SIRS vs. 2.4% with no SIRS, odds ratio 2.9, p = 0.05).
CONCLUSIONS CONCLUSIONS
Presence of SIRS in obstructive urolithiasis patients was an independent risk factor of acute urologic intervention and revisits to the ED. A timely consultation with a urologist following discharge from ED for obstructive stone patients with SIRS who had no acute renal drainage may prevent revisit to the ED. Evaluation for SIRS in addition to other clinical risk factors should be considered while making management decision in patients with acute stone obstruction.

Identifiants

pubmed: 32600324
doi: 10.1186/s12894-020-00644-z
pii: 10.1186/s12894-020-00644-z
pmc: PMC7325089
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Références

JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Intensive Care Med. 2003 Aug;29(8):1368-71
pubmed: 12830377
Scand J Trauma Resusc Emerg Med. 2018 Jul 11;26(1):56
pubmed: 29996880
Biomed Res Int. 2015;2015:792572
pubmed: 25722986
J Endourol. 2019 Jul;33(7):516-522
pubmed: 30569755
Crit Care. 2013 Jul 30;17(4):R168
pubmed: 23899120
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
CJEM. 2005 Mar;7(2):78-86
pubmed: 17355656
N Engl J Med. 2015 Apr 23;372(17):1629-38
pubmed: 25776936
J Endourol. 2013 Dec;27(12):1535-8
pubmed: 24251430
J Emerg Med. 2015 Aug;49(2):130-5
pubmed: 25910829
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Infect Chemother. 2011 Dec;17(6):764-9
pubmed: 21560033
BMC Urol. 2012 Mar 13;12:4
pubmed: 22413829
J Surg Res. 2014 Mar;187(1):237-43
pubmed: 24239146

Auteurs

Spencer Larkin (S)

Department of Urology, University of Kentucky, Lexington, KY, USA.

Jeremy Johnson (J)

Department of Urology, University of Kentucky, Lexington, KY, USA.

Trisha Venkatesh (T)

Washington University in St. Louis, St. Louis, MO, USA.

Joel Vetter (J)

Division of Urology Surgery, Washington University School of Medicine, 4960, Children's place, Campus Box 8242, St. Louis, MO, 63110, USA.

Ramakrishna Venkatesh (R)

Division of Urology Surgery, Washington University School of Medicine, 4960, Children's place, Campus Box 8242, St. Louis, MO, 63110, USA. venkateshr1@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH